The TGA has approved a drug found to slow the cognitive decline associated with Alzheimer’s disease but it will only be available for a select few who can afford it privately.
The TGA has approved a drug found to slow the cognitive decline associated with Alzheimer’s disease but it will only be available for a select few who can afford it privately. Top Stories